Burkard, M.; Niessner, H.; Leischner, C.; Piotrowsky, A.; Renner, O.; Marongiu, L.; Lauer, U.M.; Busch, C.; Sinnberg, T.; Venturelli, S.
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 2023, 12, 254.
https://doi.org/10.3390/cells12020254
AMA Style
Burkard M, Niessner H, Leischner C, Piotrowsky A, Renner O, Marongiu L, Lauer UM, Busch C, Sinnberg T, Venturelli S.
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells. 2023; 12(2):254.
https://doi.org/10.3390/cells12020254
Chicago/Turabian Style
Burkard, Markus, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M. Lauer, Christian Busch, Tobias Sinnberg, and Sascha Venturelli.
2023. "High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma" Cells 12, no. 2: 254.
https://doi.org/10.3390/cells12020254
APA Style
Burkard, M., Niessner, H., Leischner, C., Piotrowsky, A., Renner, O., Marongiu, L., Lauer, U. M., Busch, C., Sinnberg, T., & Venturelli, S.
(2023). High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells, 12(2), 254.
https://doi.org/10.3390/cells12020254